Work

Pharmacokinetics (PK) of PF-02341066, a dual ALK/MET inhibitor after multiple oral doses to advanced cancer patients.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.2596

Authors: W. Tan, K. D. Wilner, Y. Bang, E. L. Kwak, R. G. Maki, D. R. Camidge, B. J. Solomon, S. I. Ou, R. Salgia, J. W. Clark

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2282075452

Cites:

Cited by: 47

Related to: 10